These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 15023465

  • 1. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
    Krauland AH, Guggi D, Bernkop-Schnürch A.
    J Control Release; 2004 Mar 24; 95(3):547-55. PubMed ID: 15023465
    [Abstract] [Full Text] [Related]

  • 2. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
    Hombach J, Hoyer H, Bernkop-Schnürch A.
    Eur J Pharm Sci; 2008 Jan 24; 33(1):1-8. PubMed ID: 17980561
    [Abstract] [Full Text] [Related]

  • 3. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
    Krauland AH, Guggi D, Bernkop-Schnürch A.
    Int J Pharm; 2006 Jan 13; 307(2):270-7. PubMed ID: 16300914
    [Abstract] [Full Text] [Related]

  • 4. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
    Palmberger TF, Hombach J, Bernkop-Schnürch A.
    Int J Pharm; 2008 Feb 04; 348(1-2):54-60. PubMed ID: 17716840
    [Abstract] [Full Text] [Related]

  • 5. In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix.
    Guggi D, Kast CE, Bernkop-Schnürch A.
    Pharm Res; 2003 Dec 04; 20(12):1989-94. PubMed ID: 14725364
    [Abstract] [Full Text] [Related]

  • 6. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system.
    Bernkop-Schnürch A, Guggi D, Pinter Y.
    J Control Release; 2004 Jan 08; 94(1):177-86. PubMed ID: 14684281
    [Abstract] [Full Text] [Related]

  • 7. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation.
    Roldo M, Hornof M, Caliceti P, Bernkop-Schnürch A.
    Eur J Pharm Biopharm; 2004 Jan 08; 57(1):115-21. PubMed ID: 14729087
    [Abstract] [Full Text] [Related]

  • 8. The use of thiolated polymers as carrier matrix in oral peptide delivery--proof of concept.
    Bernkop-Schnürch A, Pinter Y, Guggi D, Kahlbacher H, Schöffmann G, Schuh M, Schmerold I, Del Curto MD, D'Antonio M, Esposito P, Huck C.
    J Control Release; 2005 Aug 18; 106(1-2):26-33. PubMed ID: 15939501
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and in vitro evaluation of a novel thiolated chitosan.
    Kafedjiiski K, Krauland AH, Hoffer MH, Bernkop-Schnürch A.
    Biomaterials; 2005 Mar 18; 26(7):819-26. PubMed ID: 15350788
    [Abstract] [Full Text] [Related]

  • 10. Development and in vitro evaluation of a drug delivery system based on chitosan-EDTA BBI conjugate.
    Bernkop-Schnürch A, Krauland A, Valenta C.
    J Drug Target; 1998 Mar 18; 6(3):207-14. PubMed ID: 9888307
    [Abstract] [Full Text] [Related]

  • 11. A comprehensive in vitro and in vivo evaluation of thiolated matrix tablets as a gastroretentive delivery system.
    Senyigit ZA, Vetter A, Guneri T, Bernkop-Schnürch A.
    Drug Deliv; 2011 Aug 18; 18(6):405-14. PubMed ID: 21463156
    [Abstract] [Full Text] [Related]

  • 12. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan.
    Föger F, Schmitz T, Bernkop-Schnürch A.
    Biomaterials; 2006 Aug 18; 27(23):4250-5. PubMed ID: 16618504
    [Abstract] [Full Text] [Related]

  • 13. Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate.
    Kafedjiiski K, Hoffer M, Werle M, Bernkop-Schnürch A.
    Biomaterials; 2006 Jan 18; 27(1):127-35. PubMed ID: 16045983
    [Abstract] [Full Text] [Related]

  • 14. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
    Dünnhaupt S, Barthelmes J, Hombach J, Sakloetsakun D, Arkhipova V, Bernkop-Schnürch A.
    Int J Pharm; 2011 Apr 15; 408(1-2):191-9. PubMed ID: 21295123
    [Abstract] [Full Text] [Related]

  • 15. Comparative evaluation of cytotoxicity of a glucosamine-TBA conjugate and a chitosan-TBA conjugate.
    Guggi D, Langoth N, Hoffer MH, Wirth M, Bernkop-Schnürch A.
    Int J Pharm; 2004 Jul 08; 278(2):353-60. PubMed ID: 15196640
    [Abstract] [Full Text] [Related]

  • 16. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
    Millotti G, Perera G, Vigl C, Pickl K, Sinner FM, Bernkop-Schnürch A.
    Drug Deliv; 2011 Apr 08; 18(3):190-7. PubMed ID: 21039318
    [Abstract] [Full Text] [Related]

  • 17. In vivo evaluation of a nasal insulin delivery system based on thiolated chitosan.
    Krauland AH, Leitner VM, Grabovac V, Bernkop-Schnürch A.
    J Pharm Sci; 2006 Nov 08; 95(11):2463-72. PubMed ID: 16886206
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery.
    Kafedjiiski K, Jetti RK, Föger F, Hoyer H, Werle M, Hoffer M, Bernkop-Schnürch A.
    Int J Pharm; 2007 Oct 01; 343(1-2):48-58. PubMed ID: 17544606
    [Abstract] [Full Text] [Related]

  • 19. In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein.
    Föger F, Hoyer H, Kafedjiiski K, Thaurer M, Bernkop-Schnürch A.
    Biomaterials; 2006 Dec 01; 27(34):5855-60. PubMed ID: 16919723
    [Abstract] [Full Text] [Related]

  • 20. Thiolated polymers--thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates.
    Bernkop-Schnürch A, Hornof M, Zoidl T.
    Int J Pharm; 2003 Jul 24; 260(2):229-37. PubMed ID: 12842342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.